Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer. Mol Oncol. 2012 Feb; 6(1):15-26.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.